drugset / Trial / NCT02676466

The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study

NCT02676466

RandomizedParallel-groupTriple-blindPrevention

Summary

ENRGISE Pilot Study will test the ability of anti-inflammatory interventions for preventing major mobility disability by improving or preserving walking ability.

Timeline

Start
2016-04-26
Primary completion
2018-06-22
Completion
2018-06-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified 50 mg
Subject Losartan Other / unclassified 100 mg

Indications

No indication recorded.